Vistagen Therapeutics (VTGN) Liabilities and Shareholders Equity (2011 - 2026)
Vistagen Therapeutics' Liabilities and Shareholders Equity was $35.74 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 48.2% from $68.92 million a year earlier and down 26.4% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Liabilities and Shareholders Equity at Vistagen Therapeutics came in at $48.56 million, down 42.4% from FY2025.
- Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -14.8% (FY2021 to FY2026).
- In earlier fiscal years, Liabilities and Shareholders Equity was $84.34 million in FY2025 (-31.8%), $123.65 million in FY2024 (+486.3%), $21.09 million in FY2023 (-71.7%) and $74.64 million in FY2022 (-31.1%).
- The fiscal Q1 2027 figure marks the lowest quarterly Liabilities and Shareholders Equity since fiscal Q1 2024.
- Compared with a year earlier, Liabilities and Shareholders Equity has declined for seven straight quarters, with an average decline of 12.4% over the last eight quarters.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was fiscal Q1 2025 (growth of 655.4%); the worst was fiscal Q1 2024 (a decline of 74.4%).
- Per Business Quant data, VTGN's Liabilities and Shareholders Equity in the three fiscal quarters before Q1 2027 was $48.56 million (Q4 2026), $65.06 million (Q3 2026) and $80.93 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - | 35.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.74 Mn |
| Mar 31, 2026 | 48.56 Mn |
| Dec 31, 2025 | 65.06 Mn |
| Sep 30, 2025 | 80.93 Mn |
| Jun 30, 2025 | 68.92 Mn |
| Mar 31, 2025 | 84.34 Mn |
| Dec 31, 2024 | 92.31 Mn |
| Sep 30, 2024 | 102.50 Mn |
| Jun 30, 2024 | 113.55 Mn |
| Mar 31, 2024 | 123.65 Mn |
| Dec 31, 2023 | 131.07 Mn |
| Sep 30, 2023 | 42.20 Mn |
| Jun 30, 2023 | 15.03 Mn |
| Mar 31, 2023 | 21.09 Mn |
| Dec 31, 2022 | 29.71 Mn |
| Sep 30, 2022 | 40.70 Mn |
| Jun 30, 2022 | 58.73 Mn |
| Mar 31, 2022 | 74.64 Mn |
| Dec 31, 2021 | 90.54 Mn |
| Sep 30, 2021 | 100.50 Mn |
API Access
Vistagen Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();